title: Severe hypertriglyceridaemia associated with the use of capecitabine.
authors.forename: H A
authors.initials: HA
authors.lastname: Polinder-Bos
authors.forename: E E
authors.initials: EE
authors.lastname: Kok
authors.forename: A
authors.initials: A
authors.lastname: van de Wiel
authors.forename: W
authors.initials: W
authors.lastname: Spiering
authors.forename: J P M
authors.initials: JP
authors.lastname: Wielders
authors.forename: H J
authors.initials: HJ
authors.lastname: Bloemendal
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil